PubMed |
Abstract |
RScore(About this table) |
19465749 |
Fenske W, Volker HU, Adam P, Hahner S, Johanssen S, Wortmann S, Schmidt M, Morcos M, Muller-Hermelink HK, Allolio B, Fassnacht M: Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma. Endocr Relat Cancer. 2009 Sep;16(3):919-28. Epub 2009 May 23.
|
4(0,0,0,4) |
Details |
17640764 |
Campistron M, Rouquette I, Courbon F, Chabbert V, Rochaix P, Prevot G, Laroumagne S, Tetu L, Didier A, Mazieres J: Adenoid cystic carcinoma of the lung: interest of 18FDG PET/CT in the management of an atypical presentation. Lung Cancer. 2008 Jan;59(1):133-6. Epub 2007 Jul 20.
The specificity of the liver 18FDG uptake was confirmed by Glut-1 positive immunostaining. |
1(0,0,0,1) |
Details |
19030775 |
Lee JY, Jeon BT, Shin HJ, Lee DH, Han JY, Kim HJ, Kang SS, Cho GJ, Choi WS, Roh GS: Temporal expression of AMP-activated protein kinase activation during the kainic acid-induced hippocampal cell death. J Neural Transm. 2009 Jan;116(1):33-40. Epub 2008 Nov 22.
The proteins of downstream AMPK, including those of glucose transporter1 (GLUT1) and phosphorylation of Acetyl CoA Carboxylase (ACC) were increased in the hippocampus after KA treatment. |
1(0,0,0,1) |
Details |